STOCK TITAN

cbdMD: Akretive holds 2.23M shares after acquisition

Akretive Holdings LLC is identified as a 10% owner, with the reported common-stock position held directly.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

cbdMD, Inc. (YCBD) reports that Akretive Holdings LLC, a 10% owner, held 2,229,805 shares of common stock directly following an acquisition effective October 30, 2026. The acquisition was made under an Asset Purchase Agreement dated September 1, 2026, among cbdMD, To Be Brands, LLC, Twinlab Consolidated Holdings, Inc., Philip J. Von Kahle as the duly appointed assignee, and Akretive Holdings LLC.

Insider Akretive Holdings LLC
Role 10% Owner
Type Security Shares Price Value
Holding Common Stock F1 -- -- --
Holdings: Common Stock — 2,229,805 shares (Direct)
Footnotes (1)
  1. F1. The Reporting Person acquired the shares pursuant to an Asset Purchase Agreement dated September 1, 2026, by and among the Issuer, To Be Brands, LLC, Twinlab Consolidated Holdings, Inc., Twinlab Consolidated Holdings, Inc., Philip J. Von Kahle, in his capacity as the duly appointed assignee, and the Reporting Person effective October 30, 2026.
Direct common stock position 2,229,805 shares Akretive Holdings LLC following the transaction effective October 30, 2026
Reporting-person classification 10% owner Akretive Holdings LLC
Asset Purchase Agreement date September 1, 2026 Date of the agreement under which the acquisition occurred
Acquisition effective date October 30, 2026 Effective date stated for the acquisition
Asset Purchase Agreement technical
"pursuant to an Asset Purchase Agreement"
An asset purchase agreement is a legal contract in which a buyer agrees to buy specific assets and contracts of a business rather than buying the company’s stock or ownership. It matters to investors because it determines exactly what is being bought and what liabilities stay behind — like buying the furniture and equipment from a store but not the building or past debts — which affects the deal’s value, taxes and future risk exposure.
duly appointed assignee regulatory
"Philip J. Von Kahle, in his capacity as the duly appointed assignee"
Reporting Person regulatory
"The Reporting Person acquired the shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many cbdMD shares did Akretive Holdings LLC report?

Akretive Holdings LLC reported a direct position of 2,229,805 cbdMD common shares following its acquisition effective October 30, 2026. The agreement was dated September 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Akretive Holdings LLC

(Last)(First)(Middle)
2101 WESTINGHOUSE BLVD. SUITE A

(Street)
CHARLOTTE NORTH CAROLINA 28273

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
10/30/2026
3. Issuer Name and Ticker or Trading Symbol
cbdMD, Inc. [ YCBD ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1)2,229,805D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The Reporting Person acquired the shares pursuant to an Asset Purchase Agreement dated September 1, 2026, by and among the Issuer, To Be Brands, LLC, Twinlab Consolidated Holdings, Inc., Twinlab Consolidated Holdings, Inc., Philip J. Von Kahle, in his capacity as the duly appointed assignee, and the Reporting Person effective October 30, 2026.
/s/ Patrick Ogle, Manager11/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading